T2 Biosystems Reports Granting of Inducement Award

LEXINGTON, Mass., March 07, 2018 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO) an emerging leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, announced today that it issued an inducement award to John Sprague, the Company’s recently appointed Chief Financial Officer, in accordance with the terms of Mr. Sprague’s employment offer letter.

The award was made on March 1, 2018 under T2 Biosystems’ Inducement Award Plan (the “Inducement Plan”), which was adopted March 1, 2018 and provides for the granting of equity awards to new employees of T2 Biosystems. The inducement award consists of an option to purcha…


Leave a Reply

Your email address will not be published.